Laparoscopic Pyeloplasty Registry and Database
This trial has been completed.
|Treatment||registry and database|
|Sponsor||Indiana Kidney Stone Institute|
|Start date||July 2003|
|End date||December 2016|
|Trial size||64 participants|
|Trial identifier||NCT00169650, 03-048|
The gold standard for the treatment of ureteropelvic junction obstruction (UPJO) is the open pyeloplasty. As a minimally invasive alternative, many centers are currently offering laparoscopic pyeloplasty (LP) as primary therapy for UPJOs. Recent data has shown that laparoscopic pyeloplasty has comparable success rates to open pyeloplasties and produces durable results. The researchers are compiling a registry and database to review outcomes of laparoscopic pyeloplasty patients.
To record and review the surgical outcomes of our population of UPJO patients who have been treated with LP. Once all retrospective data has been reviewed, we will continue to collect outcome data on a prospective basis
time frame: One year
All participants at least 18 years old.
Inclusion Criteria: - Male or female patients of Methodist Urology in Indianapolis, IN over the age of 18 with ureteropelvic junction obstruction Exclusion Criteria: - Patients unable to give informed consent - Patients with active bleeding diatheses - Women who are pregnant or in whom pregnancy status cannot be confirmed - Patients with medical conditions precluding laparoscopy - Patients with active urinary tract infection
|Official title||Laparoscopic Pyeloplasty: A Registry and Database|
|Principal investigator||James E Lingeman, MD|
Call for more information